Blonder Tongue Laboratories Inc - Current report filing (8-K)


 SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549



 FORM 8-K


 Current Report Pursuant to Section 13 or 15(d) of
 the Securities Exchange Act of 1934



 Date of Report (Date of earliest event reported): November 14, 2007


 Blonder Tongue Laboratories, Inc.
 (Exact Name of registrant as specified in its charter)



 Delaware 1-14120 52-1611421
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
 of incorporation) Identification No.)


 One Jake Brown Road, Old Bridge, New Jersey 08857
 (Address of principal executive offices) (Zip Code)



 Registrant's telephone number, including area code: (732) 679-4000


 Not Applicable
 (Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:


[_] Written communications pursuant to Rule 425 under the Securities Act (17
 CFR 230.425)


[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
 240.14a-12)


[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
 Exchange Act (17 CFR 240.14d-2(b))


[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
 Exchange Act (17 CFR 240.13e-4(c))











Item 2.02. Results of Operations and Financial Condition

On November 14, 2007, Blonder Tongue Laboratories, Inc. issued a press release
announcing its unaudited financial results for the third quarter ended September
30, 2007. A copy of the press release is attached to this Report as Exhibit 99.1
and is incorporated herein by reference. The information disclosed in this
report, including Exhibit 99.1 hereto, is being furnished and shall not be
deemed "filed" for purposes of Section 18 of the Securities Exchange Act of
1934.







Item 9.01. Financial Statements and Exhibits

(a) Not applicable


(b) Not applicable


(c) Not applicable


(d) The following exhibits are filed herewith:


 Exhibit 99.1 Press Release dated November 14, 2007.












 SIGNATURE


 Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

 BLONDER TONGUE LABORATORIES, INC.



 By:/s/ Eric Skolnik
 Eric Skolnik
 Senior Vice President and
 Chief Financial Officer

Date: November 14, 2007







 2









 EXHIBIT INDEX




 Exhibit No. Description

 Exhibit 99.1 Press Release of Blonder Tongue Laboratories, Inc.
 dated November 14, 2007 regarding its unaudited
 financial results for the third quarter ended
 September 30, 2007.